http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101770664-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K17-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 |
| filingDate | 2015-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101770664-B1 |
| titleOfInvention | Melittin-Polyethylene Glycol Conjugates and Pharmaceutical Composition Comprising the Same |
| abstract | The present invention provides a melittin-polyethylene glycol conjugate in which polyethylene glycol is bonded to the N-terminal amino group of melittin, a process for producing the melittin-polyethylene glycol conjugate, and a pharmaceutical composition for the treatment or prevention of inflammation containing the same as an active ingredient. The melittin-polyethylene glycol blend according to the present invention has a lower cytotoxicity and an excellent anti-inflammatory effect than melittin. |
| priorityDate | 2014-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 42.